Scopolamine hydrobromide/antipsychotics: Neuroleptic malignant syndrome (first report with scopolamine hydrobromide): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1377, 2011-01, pp. : 34-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotics/scopolamine hydrobromide: Neuroleptic malignant syndrome (first report with scopolamine): case report

By  

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Scopolamine hydrobromide: Central anticholinergic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Scopolamine hydrobromide overdose: Anticholinergic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. : 46-46

Adis International

Access to resources Recommend Favorite

Scopolamine hydrobromide overdose: Various toxicities: case report

By  

Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. : 38-38

Adis International

Access to resources Recommend Favorite

Antipsychotics: Neuroleptic malignant syndrome (first report with perospirone): 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1074, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite